Retatrutide 10mg
Triple GLP-1/GIP/GCG agonist · 10mg vial
Also known as: LY3437943, triple-agonist
Supplied for laboratory and research purposes only. Not for human consumption. Storage: 2 to 8°C after reconstitution; ambient until opened.
What is Retatrutide?
Retatrutide is an investigational triple agonist with activity at the GLP-1, GIP and glucagon receptors.
What it's studied for
Retatrutide sits in the incretin research field alongside the dual GLP-1/GIP agonists, but adds glucagon-receptor activity — which is why it draws interest in energy-expenditure and hepatic-metabolism models rather than glycaemic models alone. It remains an investigational compound and is not an approved medicine in Australia or elsewhere.
Storage & handling
Supplied lyophilised. Reconstitute with bacteriostatic water for laboratory use; store at 2-8°C once in solution and do not freeze-thaw repeatedly.
Work out the concentration for a given solvent volume, or read the full reconstitution guide.
Independently HPLC tested (99.1%). Certificate of Analysis available on request where one is on file for the lot. Supplied for laboratory and research purposes only. Not for human consumption, not for therapeutic or diagnostic use.
